Headquartered in Westbrook, ME Fiscal year ends December NASDAQ: IDXX idexx.com
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a global pet healthcare innovation company that develops and delivers diagnostic and software products and services for veterinary medicine. The company's core business is the Companion Animal Group (CAG), which encompasses point-of-care diagnostic instruments (VetLab), reference laboratory diagnostic and consulting services, rapid assay products, veterinary software, and diagnostic imaging systems. IDEXX also operates a Water quality testing business and a Livestock, Poultry and Dairy (LPD) segment. The company serves customers in more than 175 countries and territories, employs approximately 11,000 people, and is a member of the S&P 500 Index. Key platforms include the Catalyst analyzer line, IDEXX inVue Dx cellular analysis system, and ImageVue diagnostic imaging systems, alongside cloud-native veterinary practice management software. Updated
AMC Entertainment's 10.88% jump to $3.26 was the only double-digit move of the session, and the downside was where the size was: five names finished off more than 6%, led by Arm at -8.48%. Chip and consumer-tech leaders took the brunt of it.
IDEXX Laboratories just marked a new 52-week low at $520.21, undercutting its June 30 bottom by 1.18% and leaving the $41 billion vet diagnostics name roughly $230 below its November peak. That level is now the line bulls have to defend.
One of Wall Street’s top firms just gave a thumbs-up to Zoetis (NYSE:ZTS | ZTS Price Prediction) stock. Citi initiated coverage with a Buy rating and a $145 price target, naming it…
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR. There are a number of reasons for this trend, but the overall numbers are large,…
IDEXX Laboratories (NASDAQ: IDXX | IDXX Price Prediction) extended its streak of earnings beats this morning, reporting Q3 results that topped both EPS and revenue expectations while raising full-year guidance. The stock…
Joel South Pre-Market Futures: The futures are trading higher on this Halloween Friday, following a rollercoaster day on Wall Street that ultimately saw all the major indices finish in the red, with the NASDAQ…
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Caesars Entertainment, Caterpillar, CrowdStrike, Crown Castle, Electronic Arts, Estee Lauder, KeyCorp, Match, Norwegian Cruise Line, Sirius XM, SoFi Technologies and TG Therapeutics.
Friday's top analyst upgrades and downgrades included Alcoa, Blue Apron, Brixmor Property, Enterprise Products Partners, FIGS, GSK, Healthcare Realty Trust, Nordstrom, Range Resources, Southwestern Energy and Tesla.
Wednesday's top analyst upgrades and downgrades included Ally Financial, Cisco Systems, HCA Healthcare, JetBlue Airways, Juniper Networks, Snowflake, Southwest Airlines, STORE Capital, Take-Two Interactive Software and Zoetis.
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Annaly Capital Management, Clorox, Constellation Energy, Li Auto, Penn National Gaming, Teladoc Health, Transocean and Zimmer Biomet.
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh and Palantir Technologies.
The top analyst upgrades, downgrades and initiations for Monday included Apple, Caterpillar, Costco, Chipotle Mexican Grill, eBay, Groupon, Honeywell, Mastercard, Newmont Goldcorp, Roku and Zoetis.
Wednesday was a positive day for the broad U.S. markets. Crude oil continued its progress, although the gain was only marginal. The S&P 500 sectors were mostly positive.
A new report from Merrill Lynch unveils the firm's top picks for 2018. All are good choices for growth accounts with a degree of risk tolerance, and are investment picks for the…
The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Fiat Chrysler, Groupon, GrubHub, HP, IAMGOLD, JD.com and Salesforce.com.
24/7 Wall St. tracked the best performing members of the S&P 500 Index on a year-to-date basis. It turns out that seven of the 500 stocks have gains of between 30% and…
Credit Suisse made a point to highlight a few animal health companies that stand to outperform the markets in 2016 and even beyond.
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a global pet healthcare innovation company that develops and delivers diagnostic and software products and services for veterinary medicine.
24/7 Wall St.'s 12-month price target for IDXX is $663.27, rated Buy. The Wall Street consensus target is $701.33. IDXX price prediction →
